Combined Inhibition of CDK4/6 and AKT is Highly Effective Against the Luminal Androgen Receptor (LAR) Subtype of Triple Negative Breast Cancer.
CANCER RESEARCH（2024）
Key words
CDK4/6 Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined